Abstract | BACKGROUND: RESEARCH DESIGN AND METHODS: From the Korean nationwide registry, seven subjects with previous DHS were included. Their HLA allele/phenotype frequencies were compared with 8 dapsone-tolerant subjects recruited from a single institution, and general population (n = 485) in Korea. The authors also performed a meta-analysis with these data using previous Chinese and Thai studies. RESULTS: Among the seven DHS subjects, 85.7% presented with the HLA-B*13:01 allele. The HLA-C*03:04, HLA-DRB1*12:02 (both in linkage disequilibrium with HLA-B*13:01), and HLA-A*02:01 alleles were also presented in 85.7%, 71.4%, and 71.4%, respectively. Subjects with HLA-B*13:01 were susceptible to developing DHS compared to dapsone-tolerant controls (odds ratio [OR]: 73.667) and the Korean general population (OR: 139.500). HLA-C*03:04 (OR: 40.935), HLA- DRB*12:02 (OR: 36.613), and HLA-A*02:01 (OR: 5.862) showed similar results. In meta-analysis, HLA-B*13:01 was associated with dapsone-induced hypersensitivity (overall OR: 42.692), and subgroup analyses according to the control types demonstrated similar results (OR:43.694 and 41.866, respectively). CONCLUSIONS: Similar to previous Asian population studies, HLA-B*13:01 is significantly associated with the risk of DHS in Korea. These associations may be useful for preventing DHS and improving drug safety.
|
Authors | Hye Jung Park, Jung-Won Park, Sae Hoon Kim, So-Yun Choi, Hee-Kyoo Kim, Chang-Gyu Jung, Min-Suk Yang, Dong Yoon Kang, Min-Kyoung Cho, Hyouk-Soo Kwon, Hye-Ryun Kang, Yong Won Lee, Allergy Work Group of KAAACI |
Journal | Expert opinion on drug safety
(Expert Opin Drug Saf)
Vol. 19
Issue 10
Pg. 1349-1356
(Oct 2020)
ISSN: 1744-764X [Electronic] England |
PMID | 32700588
(Publication Type: Journal Article, Meta-Analysis)
|
Chemical References |
- HLA-B13 Antigen
- Leprostatic Agents
- Dapsone
|
Topics |
- Adult
- Aged
- Asian People
(genetics)
- Child
- Dapsone
(administration & dosage, adverse effects)
- Drug Hypersensitivity Syndrome
(etiology, genetics)
- Female
- Genotype
- HLA-B13 Antigen
(genetics)
- Humans
- Leprostatic Agents
(administration & dosage, adverse effects)
- Male
- Middle Aged
- Registries
- Republic of Korea
- Risk Factors
|